Article
Suberoylanilide hydroxamic acid induces hypersensitivity to radiation therapy in acute myelogenous leukemia cells expressing constitutively active FLT3 mutants.
PloS one - 1 Jan 2013
Chen Xufeng, Radany Eric H, Wong Patty, Ma Shenglin, Wu Kan, Wang Bing, Wong Jeffrey Y C
Abstract excerpt
Histone deacetylase inhibitors (HDIs) have shown promise as candidate radiosensitizer for many types of cancers. However, the mechanisms of action are not well understood, and whether they could have clinical impact on radiotherapy for leukemia is unclear. In this study, we demonstrate that suberoylanilide hydroxamic acid (SAHA) can increase radiosensitivity of acute myeloid leukemia (AML) cells through...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
